Allergy, Asthma & ClinicalImmunology, the official journal of theCanadian Society of Allergy and
Clinical Immunology(CSACI), has now
commenced publication with BioMed Central, having transferred to our open access
publishing format with the aim of increasing the success of the
journal.
AACIaims to further the understanding and treatment of allergic
and immunologic disease by providing a platform for the dissemination of
research and reviews that help elucidate normal immune mechanisms and the ways
in which these mechanisms become dysfunctional.Thelaunch articlesincludea discussion byGilleset
alregarding the
involvement of pollen associated lipid mediators (PALMS) in the allergic
response to pollen anda review bySoniaMichailassessing the evidence surrounding the benefits
of probiotic use in treating allergic disease.
and immunologic disease by providing a platform for the dissemination of
research and reviews that help elucidate normal immune mechanisms and the ways
in which these mechanisms become dysfunctional.Thelaunch articlesincludea discussion byGilleset
alregarding the
involvement of pollen associated lipid mediators (PALMS) in the allergic
response to pollen anda review bySoniaMichailassessing the evidence surrounding the benefits
of probiotic use in treating allergic disease.
Editor-in-Chief,
Richard Warrington explains in his inauguralEditorial"[TheCSACI
is]one of the oldest medical
specialty societies in Canadaand
dedicated to the advancement of the knowledge and practice of allergy, clinical
immunology, and asthma, and the provision of optimal patient care" andcommenting on their decision to transfer the journal to BioMed
Central"we, the Editors-in-Chief of AACI and the Board of
Directors of CSACI, have decided that our journal should become an open-access
journal because we believe that medical knowledge should be freely available to
all".
Richard Warrington explains in his inauguralEditorial"[TheCSACI
is]one of the oldest medical
specialty societies in Canadaand
dedicated to the advancement of the knowledge and practice of allergy, clinical
immunology, and asthma, and the provision of optimal patient care" andcommenting on their decision to transfer the journal to BioMed
Central"we, the Editors-in-Chief of AACI and the Board of
Directors of CSACI, have decided that our journal should become an open-access
journal because we believe that medical knowledge should be freely available to
all".
For further information about the journal, please visit thejournal websiteor
view theinstructions for
authorsif you would like
to submit a manuscript.
view theinstructions for
authorsif you would like
to submit a manuscript.
Comments